Evidence map›Paper›PMID 34646731›Full record

ArticleRespiratory medicine case reports2021

Pulmonary hypertension due to silicosis and right upper pulmonary artery occlusion with bronchial anthracofibrosis.

Kai Yazaki, Kazufumi Yoshida, Kentaro Hyodo, Jun Kanazawa, Takefumi Saito, Nobuyuki Hizawa

Open access · goldAbstract readCase Reports
In one paragraph

Article in Respiratory medicine case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kai YazakiDepartment of Respiratory Medicine, National Hospital Organization, Ibarakihigashi National Hospital, Tokai, Japan.
Kazufumi YoshidaDepartment of Respiratory Medicine, National Hospital Organization, Ibarakihigashi National Hospital, Tokai, Japan.
Kentaro HyodoDepartment of Respiratory Medicine, National Hospital Organization, Ibarakihigashi National Hospital, Tokai, Japan.
Jun KanazawaDepartment of Respiratory Medicine, National Hospital Organization, Ibarakihigashi National Hospital, Tokai, Japan.
Takefumi SaitoDepartment of Respiratory Medicine, National Hospital Organization, Ibarakihigashi National Hospital, Tokai, Japan.
Nobuyuki HizawaDepartment of Pulmonary Medicine, University of Tsukuba, Tsukuba, Japan.
University of Tsukuba · JPNational Hospital Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bronchial anthracofibrosis is a rare disease defined as bronchial stenosis with black pigmentation and usually not associated with artery occlusion. The patient was an 81-year-old man with silicosis. He presented with dyspnea on exertion, and pulmonary hypertension due to right upper pulmonary artery occlusion without thromboembolism was diagnosed on the basis of the results of right heart catheterization and pulmonary angiography. Bronchoscopy demonstrated bronchial anthracofibrosis in the right upper lobe. These findings suggested that the cause of PH was silicosis and pulmonary artery occlusion with bronchial anthracofibrosis. He has been treated with home oxygen therapy and tadalafil, and his symptom and 6MWD remain stable.

Indexed as

Bronchial anthracofibrosisPulmonary artery occlusionPulmonary hypertensionSilicosis

Identifiers

PMID34646731
PMCPMC8497993
OpenAlexW3202424457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.